Navigation Links
CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Date:9/11/2008

or Stage IV melanoma. Eligible patients had progressive disease at trial entry and may have received one prior cytotoxic regimen and any number of prior immunotherapies. Clinical efficacy endpoints include objective response rate, progression free rate, time to response and duration of response.

CuraGen is also continuing the Phase I portion of the trial evaluating the use of a weekly as well as a two out of every three week regimen of CR011-vcMMAE to explore the optimal dose and schedule of administration. Results from these more frequent dosing schedules are expected to be available in the first half of 2009.

In addition, CR011-vcMMAE is being studied in an ongoing Phase II trial in patients with metastatic breast cancer who have received previous chemotherapy. It is anticipated that preliminary results from the breast cancer trial will be presented in the first half of 2009.

CR011-vcMMAE targets glycoprotein NMB (GPNMB), which is overexpressed in a variety of cancers including melanoma, breast cancer and brain tumors. CR011-vcMMAE is an antibody-drug conjugate comprised of a fully-human monoclonal antibody against GPNMB linked to a potent tubulin destabilizing agent, monomethyl auristatin E (MMAE). The enzyme-sensitive linker, which was licensed from Seattle Genetics, is designed to be stable in the bloodstream and to release MMAE inside tumor cells, resulting in cancer cell death.

iSBTc Presentation Details

Title: Phase I/II Study of CR011-vcMMAE, an Antibody-Drug Conjugate

targeting GPNMB, for the Treatment of Patients with Advanced

Melanoma

Type: Oral presentation

Presenter: Dr. Patrick Hwu

Session: Tumor Targeting Monoclonal Antibodies

Date/Time: November 1, 2008 from 2:45 p.m. to 4:15 p.m.

About Melanoma

According to the American Cancer Society, it is expected that approximately 60,000 new cases of melanoma will be diagnosed, i
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... , Sept. 3, 2015  As part of its ... heart disease, Marc R. Katz , MD, MPH, ... Secours Heart & Vascular Institute implanted the first HeartMate ... The patient was selected as part of the prestigious ... 60 elite centers in the United States—and the first ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... the "Investigation Report on China,s Trastuzumab Market, 2010-2019" ... Genentech, trastuzumab was approved by FDA to be used ... name of Herceptin, a major product of Roche. In ... billion around the world. After entering ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... Sept. 27, 2011 As a result of the ... be dangerous to their health, according to Consumer Reports, ... currently take a prescription medicine told pollsters they,d cut ... visit or medical procedure, declining tests, or ordering cheaper ...
... WASHINGTON, Sept. 27, 2011 More than 60 medical ... the globe will present their technologies at AdvaMed ... diagnostic companies and academic tech transfer offices will make ... business leaders, angel, private equity, and venture capital investors, ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 2Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 3Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 4Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 5
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop announced availability ... as part of the LANDESK One Partner program. Splashtop remote desktop ... mobile user experience in remote access and control:, , ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, professional ... her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” , ... guide to overcoming life’s obstacles by taking full responsibility for one’s life shares ...
(Date:9/3/2015)... ... September 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project ... 6205 Kate Road in Monroe, North Carolina. The event food will be ... function, Kate Clyde’s offers off-premise catering and event services from casual to elegant. They ...
(Date:9/3/2015)... ... September 03, 2015 , ... For ... in its Annual Inc. 5000 list of fastest-growing private companies in America. ... fraction of the nation's companies have demonstrated such remarkably consistent high growth, particularly ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief executive officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... 2008 Elsevier and the Alzheimer,s ... Journal of the Alzheimer,s Association ( www.alzheimersanddementia.org ... MEDLINE (www.pubmed.gov) is the premier bibliographic database of ... the National Institutes of Health (NIH), MEDLINE contains ...
... The editors of Neurotherapeutics are pleased ... to "Novel Therapeutics for Alzheimer,s Disease." Neurotherapeutics ... American Society of Experimental NeuroTherapeutics (ASENT) www.asent.org ... Alzheimer,s Association International Conference on Alzheimer,s Disease (ICAD), ...
... 24 The Connecticut,Hospice, Inc., birthplace of Hospice ... six Nurse Scholars from The Henrietta Szold-Hadassah-Hebrew,University School ... University College of Nursing., Lauren Brown, MSN, ... of the Norma F. Pfriem International,Fellowship in Hospice ...
... exclusive brand, of home health care products, ... calling ... As consumerism, the,aging patient population and evolving government ... Cardinal Health today launched new,tools to help retail independent ...
... AHA-McKesson Quest for Quality Prize, ANN ARBOR, Mich., ... of the University of Michigan Health,System provide some of ... of the safest, too. That,s according to the American ... lone finalist,for a major annual award., U-M comes ...
... Horizon Therapeutics, Inc.,a privately held biopharmaceutical company, ... president, chief executive officer and member of the,board ... a long, proven track record of successfully commercializing,multi-billion ... said George,Tidmarsh, M.D., Ph.D., founder, scientific consultant and ...
Cached Medicine News:Health News:Alzheimer's & Dementia: The Journal of the Alzheimer's Association accepted for coverage in MEDLINE 2Health News:Neurotherapeutics presents special issue on new treatments for Alzheimer's disease 2Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 2Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 3Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 4Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 5Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 2Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 3Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 4Health News:Horizon Therapeutics Names Timothy P. Walbert as President and CEO 2
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
... to seal the ABI PRISM Optical 384-Well ... Systems only, not compatible with Sequence Detection ... With:, Dual 384-Well, GeneAmp PCR System 9700, ... Plate with Barcode (code 128), Auto-Lid Dual ...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
Medicine Products: